MiR-92a was previously confirmed to be significantly up-regulated in various cancers and to contribute to tumor progression by targeting the FBXW7 protein, which is a critical tumor suppressor and one of the most important molecules involved in the ubiquitin–proteasome system [56,57]. The gene discussed is FBXW7; the disease is cancer.